Lilly hikes revenue forecast by $2B as GLP-1 drug sales climb
Bio Pharma Dive
APRIL 30, 2024
Supply continues to be tight, however, and the company anticipates further sales growth to be limited by how quickly it can bring on additional production capacity.
Let's personalize your content